| Roche Pharma (Schweiz) AG - Lunsumio subkutan 45 mg/1ml, Injektionslösung | | 70221 | | 02 | | Lunsumio subkutan 45 mg/1ml | | Injektionslösung | | L01FX25 | | Mosunetuzumab | | 03.07.2026 | | |
| | Composition | | mosunetuzumabum 45 mg, histidinum, acidum aceticum glaciale, saccharum, methioninum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. | | Packungsbestandteile | | Injection solution | | | | | | Active Agent | Dose |
|---|
| Mosunetuzumabum | 45 mg/ml |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Histidine | | Methionine | | Polysorbatum 20 | | Saccharum |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | | | A | | Yes |
|
|
